Practical Assessment of an Interdisciplinary Bacteriophage Delivery Pipeline for Personalized Therapy of Gram-Negative Bacterial Infections
Open Access
- 2 February 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (2) , 186
Abstract
Despite numerous advances in personalized phage therapy, smooth logistics are challenging, particularly for multidrug-resistant Gram-negative bacterial infections requiring high numbers of specific lytic phages. We conducted this study to pave the way for efficient logistics for critically ill patients by (1) closely examining and improving a current pipeline under realistic conditions, (2) offering guidelines for each step, leading to safe and high-quality phage supplies, and (3) providing a tool to evaluate the pipeline’s efficiency. Due to varying stipulations for quality and safety in different countries, we focused the pipeline on all steps up to a required phage product by a cell-free extract system. The first of three study runs included patients with respiratory bacterial infections from four intensive care units, and it revealed a cumulative time of up to 23 days. Ultimately, adjustment of specific set points of the vulnerable components of the pipeline, phage isolation, and titration increased the pipeline’s efficiency by 15% and decreased the maximum required time to 13 days. We present a site-independent practical approach to establish and optimize pipelines for personalized phage delivery, the co-organization of pipeline components between different institutions, non-binding guidelines for every step, and an efficiency check for phage laboratories.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (395357507-SFB 1371)
- Technische Universität München (Open Access Publishing Program)
- Bundesinstitut für Risikobewertung (43-001)
This publication has 82 references indexed in Scilit:
- Campylobacter group II phage CP21 is the prototype of a new subgroup revealing a distinct modular genome organization and host specificityBMC Genomics, 2015
- Quality and Safety Requirements for Sustainable Phage Therapy ProductsPharmaceutical Research, 2015
- wzi Gene Sequencing, a Rapid Method for Determination of Capsular Type for Klebsiella StrainsJournal of Clinical Microbiology, 2013
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Protocols for Implementing an Escherichia coli Based TX-TL Cell-Free Expression System for Synthetic BiologyJournal of Visualized Experiments, 2013
- Phage Cocktails and the Future of Phage TherapyFuture Microbiology, 2013
- Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniaeVirology Journal, 2013
- Phage Therapy Pharmacology2012
- Clinical Aspects of Phage Therapy2012
- The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?Pharmaceutical Research, 2010